About Actin, alpha cardiac muscle 1
Actin, alpha cardiac muscle 1 (ACTC1) is a protein
from Homo sapiens identified by UniProt accession
P68032, 377 residues long.
MolForge cross-references it against 0 known binders and
138 disease associations.
Target properties
| Protein name | Actin, alpha cardiac muscle 1 |
| UniProt accession | P68032 |
| Gene | ACTC1 |
| Organism | Homo sapiens |
| Length | 377 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (138)
Diseases linked to this target (Open Targets).
- hypertrophic cardiomyopathy · score 0.80
- hypertrophic cardiomyopathy 11 · score 0.79
- atrial septal defect 5 · score 0.73
- left ventricular noncompaction · score 0.71
- Rare familial disorder with hypertrophic cardiomyopathy · score 0.55
- Abnormality of the cardiovascular system · score 0.47
- cardiomyopathy · score 0.46
- familial hypertrophic cardiomyopathy · score 0.44
- dilated cardiomyopathy · score 0.42
- familial isolated dilated cardiomyopathy · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P68032-F1 | alphafold | PREDICTED | 95.36 | — |
Amino-acid sequence (377 residues)
MCDDEETTAL VCDNGSGLVK AGFAGDDAPR AVFPSIVGRP RHQGVMVGMG QKDSYVGDEA QSKRGILTLK YPIEHGIITN WDDMEKIWHH TFYNELRVAP EEHPTLLTEA PLNPKANREK MTQIMFETFN VPAMYVAIQA VLSLYASGRT TGIVLDSGDG VTHNVPIYEG YALPHAIMRL DLAGRDLTDY LMKILTERGY SFVTTAEREI VRDIKEKLCY VALDFENEMA TAASSSSLEK SYELPDGQVI TIGNERFRCP ETLFQPSFIG MESAGIHETT YNSIMKCDID IRKDLYANNV LSGGTTMYPG IADRMQKEIT ALAPSTMKIK IIAPPERKYS VWIGGSILAS LSTFQQMWIS KQEYDEAGPS IVHRKCF
Explore Actin, alpha cardiac muscle 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets